跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
CPT-1
首页
药物
CPT-1
CPT-1
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Novel compounds, pharmaceutical compositions containing same, and methods of use for same
EP 2386550 A1
申请人: FASGEN INC
优先权: 2003
EP
US
5 件公开
Stimulation of CPT-1 as a means to reduce weight
US 2005106217 A1
申请人: JOHNS HOPKINS UNIVERSITY LICEN
优先权: 2004
US
5 件公开
Compositions for the improvement of obesity
US 2005130912 A1
申请人: PARK HYUN-WOO
优先权: 2003
CN
US
WO
4 件公开
Process for the manufacture of intermediates in camptothecin production
US 7423152 B2
申请人: HOFFMANN LA ROCHE
优先权: 2005
CN
US
3 件公开
Inhibitors of fatty acid oxidation for prophylaxis and treatment of diseases related to mitochondrial dysfunction
US 2010034796 A1
申请人: MEDIGENE AG
优先权: 2004
US
3 件公开
Use of CPT-1 Modulators and Compositions Thereof
US 2013224318 A1
申请人: AVON PROD INC
优先权: 2013
CN
US
2 件公开
Composition of skin external application containing ginseng berry extracts
US 8877264 B2
申请人: PARK CHAN WOONG
优先权: 2007
US
2 件公开
Inhibitors of carnitin-palmitoyl-tranferase-1 for the treatment and prevention of disorders caused by delipidation of neural tissue
US 8741949 B2
申请人: NIELAND JOSEPHUS DIRK
优先权: 2009
US
2 件公开
Treating cancer by increasing intracellular malonyl coA levels
EP 1728510 A2
申请人: UNIV JOHNS HOPKINS MED
优先权: 2000
EP
US 2002187534 A1
申请人: PIZER ELLEN S
优先权: 2002
US
Hydrosoluble mixtures of cyproterone and/or an ester of it, processes to obtain them and uses thereof
EP 1316317 A1
申请人: UNIV LIEGE
优先权: 2001
EP
第 1 / 6 页
上一页
下一页
药物
反馈